- Home
- VRDN vs ASTH Comparison
VRDN vs ASTH Comparison
Compare VRDN & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- ASTH
- Stock Information
- Founded
- VRDN 2006
- ASTH 1994
- Country
- VRDN United States
- ASTH United States
- Employees
- VRDN N/A
- ASTH N/A
- Industry
- VRDN Medical Specialities
- ASTH Professional Services
- Sector
- VRDN Health Care
- ASTH Consumer Discretionary
- Exchange
- VRDN Nasdaq
- ASTH Nasdaq
- Market Cap
- VRDN 1.6B
- ASTH 1.3B
- IPO Year
- VRDN N/A
- ASTH N/A
- Fundamental
- Price
- VRDN $20.78
- ASTH $29.65
- Analyst Decision
- VRDN Strong Buy
- ASTH Strong Buy
- Analyst Count
- VRDN 10
- ASTH 7
- Target Price
- VRDN $36.33
- ASTH $50.50
- AVG Volume (30 Days)
- VRDN 718.1K
- ASTH 329.9K
- Earning Date
- VRDN 11-11-2025
- ASTH 11-06-2025
- Dividend Yield
- VRDN N/A
- ASTH N/A
- EPS Growth
- VRDN N/A
- ASTH N/A
- EPS
- VRDN N/A
- ASTH 0.52
- Revenue
- VRDN $305,000.00
- ASTH $2,419,115,000.00
- Revenue This Year
- VRDN N/A
- ASTH $60.87
- Revenue Next Year
- VRDN $34,044.63
- ASTH $27.04
- P/E Ratio
- VRDN N/A
- ASTH $56.54
- Revenue Growth
- VRDN 5.90
- ASTH 51.97
- 52 Week Low
- VRDN $9.90
- ASTH $21.20
- 52 Week High
- VRDN $27.20
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- VRDN 54.30
- ASTH 53.23
- Support Level
- VRDN $20.69
- ASTH $27.64
- Resistance Level
- VRDN $22.37
- ASTH $31.18
- Average True Range (ATR)
- VRDN 0.97
- ASTH 1.29
- MACD
- VRDN -0.06
- ASTH 0.08
- Stochastic Oscillator
- VRDN 54.71
- ASTH 59.63
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.